Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9334-9342
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9334
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9334
Table 1 Patient characteristics, survival and best response to treatment n (%)
Age (yr) | Median (62.2) | Range (32-84) | ||
Sex | Male | Female | ||
67 (51.9) | 62 (48.1) | |||
BTC subtype | EHC | IHC | GBC | Total |
45 (34.9) | 50 (38.8) | 34 (26.4) | 129 | |
Stage | I | II | III | IV |
10 (7.8) | 20 (15.5) | 40 (31.0) | 65 (50.4) | |
Grade | G1 | G2 | G3 | |
7 (5.4) | 81 (62.8) | 41 (31.8) | ||
Treatment | BSC | Cx | Sx | Total |
56 (43.4) | 64 (49.6) | 9 (7.0) | 129 | |
Response to Cx | PR | SD | PD | |
11 (17.2) | 27 (42.2) | 26 (40.6) | ||
OS | BSC | Cx | Sx | All |
(mo) | 15.1 | 17.7 | 41.8 | 18.3 |
- Citation: Harder J, Müller MJ, Fuchs M, Gumpp V, Schmitt-Graeff A, Fischer R, Frank M, Opitz O, Hasskarl J. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer. World J Gastroenterol 2013; 19(48): 9334-9342
- URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9334